SPS
IDYA icon

Susquehanna Portfolio Strategies’s IDEAYA Biosciences IDYA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.63M Buy
204,659
+2,225
+1% +$68.1K 0.12% 214
2026
Q1 		$6.75M Hold
202,434
– – 0.1% 254
2025
Q4 		$7M Buy
202,434
+39,171
+24% +$1.25M 0.11% 253
2025
Q3 		$4.44M Buy
+163,263
New +$3.95M 0.07% 335

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Susquehanna Portfolio Strategies's IDYA Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its IDEAYA Biosciences (IDYA) stake by 1.1% in Q2 2026, buying an estimated $68.1K and bringing the position to 204,659 shares worth $7.63M. The position accounts for 0.12% of the portfolio, ranked #214.

Susquehanna Portfolio Strategies first reported a position in IDYA in Q3 2025 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Susquehanna Portfolio Strategies held 204,659 shares of IDEAYA Biosciences worth $7.63M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 2,225 IDEAYA Biosciences shares in Q2 2026, an estimated $68.1K.
  • IDEAYA Biosciences made up 0.12% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #214 holding.
  • Susquehanna Portfolio Strategies first reported a position in IDEAYA Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.